Insider · CIK 0001313397
Richard J Rodgers
director
Files at NVAX (NOVAVAX INC), IRD (Opus Genetics, Inc.), ARDX (ARDELYX, INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 20, 2025 | NVAX NOVAVAX INC | AGrant or award Stock Option (Right to Buy)derivative | +28,326 | $6.42 | $182k | 28,326 | Jun 24, 2025 |
| Jun 20, 2025 | NVAX NOVAVAX INC | AGrant or award Restricted Stock Unitsderivative | +18,884 | $0.00 | $0 | 18,884 | Jun 24, 2025 |
| Jun 18, 2025 | ARDX ARDELYX, INC. | AGrant or award Common Stock | +21,468 | $0.00 | $0 | 371,992 | Jun 23, 2025 |
| Jun 18, 2025 | ARDX ARDELYX, INC. | AGrant or award Common Stock | +41,551 | $0.00 | $0 | 413,543 | Jun 23, 2025 |
| Jun 18, 2025 | ARDX ARDELYX, INC. | AGrant or award Stock Option (Right to Buy)derivative | +54,059 | $0.00 | $0 | 54,059 | Jun 23, 2025 |
| Jun 12, 2025 | NVAX NOVAVAX INC | MOption exercise Common Stock | +10,420 | $0.00 | $0 | 24,690 | Jun 13, 2025 |
| Jun 12, 2025 | NVAX NOVAVAX INC | MOption exercise Restricted Stock Unitsderivative | -10,420 | $0.00 | $0 | 0 | Jun 13, 2025 |
| Apr 30, 2025 | IRD Opus Genetics, Inc. | AGrant or award Common Stock | +79,504 | $0.00 | $0 | 318,655 | May 2, 2025 |
| Apr 30, 2025 | IRD Opus Genetics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +79,592 | $0.00 | $0 | 79,592 | May 2, 2025 |
| Jan 16, 2025 | ARDX ARDELYX, INC. | MOption exercise Common Stock | +100,000 | $0.55 | $55k | 350,524 | Jan 17, 2025 |
| Jan 16, 2025 | ARDX ARDELYX, INC. | MOption exercise Stock Option (Right to Buy)derivative | -100,000 | $0.00 | $0 | 0 | Jan 17, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.